Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||0.01%||167.59||0.7%||$1123.19m|
|LLY||Eli Lilly & Co.||2.11%||316.85||1.1%||$810.94m|
|MRK||Merck & Co., Inc.||0.46%||91.01||0.7%||$787.57m|
|BMY||Bristol-Myers Squibb Co.||0.57%||74.55||1.0%||$638.52m|
|SIGA||SIGA Technologies, Inc.||1.85%||24.77||0.0%||$466.92m|
|GBT||Global Blood Therapeutics, Inc.||0.00%||67.00||5.6%||$344.80m|
|ALNY||Alnylam Pharmaceuticals, Inc.||-2.20%||223.13||8.2%||$270.05m|
|HZNP||Horizon Therapeutics Plc||-3.67%||61.73||5.4%||$222.09m|
|KRTX||Karuna Therapeutics, Inc.||-0.93%||261.23||0.0%||$204.24m|
Corvus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, and Joseph J. Buggy on January 27, 2014 and is headquartered in Burlingame, CA.